CyberKnife®, an innovative treatment for cancers of the kidneys, is a non-invasive radiosurgery technique.
As explained by Consultant Clinical Oncologists Andrew Gaya and Nick Plowman in the following articles, CyberKnife® technology is able to target tumours accurately and deliver radiation with sub-millimetre precision, making it possible to give a large radiation dose, lethal to the tumour, with little risk to the surrounding tissues and minimal side effects.
Renal cancers cannot be treated with chemotherapy and usually require large doses of radiation to be removed; this form of therapy is thereby limited by the dose the surrounding tissues can tolerate. The ability of CyberKnife® to focus radiation solely on the tumour is hugely beneficial in this case.
CyberKnife® treatment normally takes an hour and is given in up to five treatments. It is suitable for tumours all over the body and can be used as an alternative to invasive surgery.
In the following articles, doctors Nick Plowman, Andrew Gaya, and Chris Nutting give expert advice on CyberKnife®.
See also - Treating Kidney Cancer by Tumour Ablation - latest cancer treatment advances by Kidney Cancer Specialist Dr Rowland Illing
Contact a doctor about treatment with CyberKnife®.
About Kidney Cancer
Kidney cancer is a fairly common type of cancer, the most common form of which is renal cell carcinoma. It accounts for approximately 2–3% of adult cancers with risk factors including smoking and obesity, leading to huge surges in the numbers of people diagnosed. Treatment options include nephrectomy, embolisation (starving the kidneys of blood) as well as radiotherapy and immunotherapy